| Financial Year |
March 31 2023 |
| Monetary Funds |
728,894,392.95 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,386,146,884.53 |
| Advances to Suppliers |
100,717,945.91 |
| Other Receivables |
61,546,516.72 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,908,428,346.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
14,900,252.19 |
| Other Current Assets |
463,977,786.68 |
| Total Current Assets |
6,022,050,762.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
93,084,930.65 |
| Investment Properties |
-- |
| Fixed Assetes |
5,621,106,837.00 |
| Under-construction Projects |
2,095,256,324.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
505,025,051.88 |
| R&D expenses |
-- |
| Goodwill |
5,897,874.00 |
| Long-Term Deferred and Prepaid Expenses |
348,455.50 |
| Deferred Income Tax Assets |
67,939,692.43 |
| Other Non-Current Assets |
238,300,927.90 |
| Sub-Total of Non-Current Assets |
8,664,589,169.79 |
| Total Assets |
14,686,639,932.71 |
| Short-Term Loans |
1,273,892,681.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,194,865,198.15 |
| Accounts Payable |
1,359,855,364.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
149,063,335.58 |
| Taxes Payable |
77,774,716.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
165,090,738.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
256,309,609.86 |
| Other Current Liabilities |
5,717,687.56 |
| Sub-Total of Current Liabilities |
4,601,150,234.79 |
| Long-term Loans |
2,086,153,500.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,475,378.77 |
| Other Non-Current Liabilities |
515,949,713.36 |
| Sub-Total of Non-Current Liabilities |
2,738,259,109.02 |
| Total Liabilities |
7,339,409,343.81 |
| Paid-In Capital(Or Share Stock) |
923,246,256.00 |
| Capital Surplus |
2,233,377,147.51 |
| Surplus Reserve |
356,953,844.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,496,382,918.65 |
| Minority Stockholder's Interest |
329,037,156.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,018,193,432.46 |
| Owner's Equity（Stockholder's Equity） |
7,347,230,588.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,686,639,932.71 |
